ENDRA Life Sciences Inc.
NDRA
$4.09
-$0.0519-1.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 45.01% | 62.67% | -184.28% | 24.08% | 12.82% |
| Total Depreciation and Amortization | -34.53% | -18.13% | -24.18% | -23.30% | -31.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.95% | -169.40% | 474.56% | 245.79% | -81.05% |
| Change in Net Operating Assets | 11.86% | -78.35% | 117.74% | -229.07% | 218.00% |
| Cash from Operations | 46.54% | 39.70% | 30.30% | 36.23% | 8.17% |
| Capital Expenditure | -100.00% | 35.93% | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | 27.31% | -100.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -88.32% | -70.69% | -100.00% | -- | 55.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Financing | -88.32% | -68.91% | -100.00% | -99.85% | 55.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -104.87% | 31.46% | -202.78% | -11.49% | 113.70% |